SerraSilk (Serrapeptase) has wide clinical use spanning over twenty five years throughout Europe and Asia as a viable alternative to salicylates, ibuprofen and the more potent NSAIDs. Unlike these drugs, SerraSilk is a naturally occuring, physiologic agent with no inhibitory effects on prostaglandins and is devoid of gastrointestinal side effects. SerraSilk is a proteolytic enzyme isolated from the micro-organism, Serratia E15. This enzyme is naturally present in the silkworm intestine and is processed commercially today through fermentation. This immunologically active enzyme is completely bound to the alpha-2 macroglobulin in biological fluids. Histologic studies reveal powerful anti-inflammatory effects of this naturally occuring enzyme. SerraSilk digests non-living tissue, blood clots, cysts, and arterial plaque and inflammation in all forms. The late German physician, Dr. Hans Nieper, used Serrapeptase to treat arterial blockage in his coronary patients. Serrapeptase protects against stroke and is more effective and quicker than EDTA chelation treatments in removing arterial plaque. He also reports that serrapeptase dissolves blood clots and causes varicose veins to shrink or diminish. Dr. Nieper told of a woman scheduled for hand amputation and a man scheduled for bypass surgery who both recovered quickly without surgery after treatment with serrapeptase.
SERVING SIZE: 1 Capsule
SERVINGS PER CONTAINER: 60
AMOUNT PER SERVING:
Serratia Peptidase (40,000 units) 400 mg